Collections
Bibliography
Subscribe and Share
Links
Thursday, July 25, 2024

500K JUUL and Opioid Documents Added to IDL

Collection Updates

New Opioid Industry Documents Archive Collection - Teva and Allergan Documents

OIDA staff released the first tranche from its newest collection, the Teva and Allergan Documents. This first batch numbers more than 120,000 documents; the collection will encompass about 1.9 million documents when complete.

Teva Pharmaceuticals, an Israeli company, is one of the United States’ biggest manufacturers of generic opioids, including oxycodone. Teva also manufactures the branded fentanyl products Actiq and Fentora. Ireland-based Allergan formerly made Norco- and Kadian-branded and generic opioids.

Teva acquired Cephalon in 2011 as a wholly-owned subsidiary of Teva Ltd., which added Actiq and Fentora to Teva’s portfolio. In 2016, Teva acquired Allergan’s generics business, Actavis. Allergan/Actavis was the second largest manufacturer to supply generic opioids to the United States, following Mallinckrodt. Allergan was acquired by AbbVie in 2019.

On November 23, 2022, attorneys general in eight states announced that proposed nationwide settlements totaling $6.6 billion had been reached with Teva and Allergan, resolving allegations that they contributed to the opioid crisis by illegally marketing their opioids and failing to maintain effective diversion controls. The nationwide settlements, which became effective in August 2023, call for Teva to pay a total of $4.24 billion over 13 years and Allergan to pay $2.37 billion over seven years.

The settlements prohibit Teva and Allergan from promoting opioids, directly and through front groups, and from engaging in opioid-related lobbying activities. The settlements also require the companies to turn over for public disclosure millions of internal documents they produced in the litigation.

Documents in the collection so far include emails, spreadsheets, presentations, reports, sales training materials, speaker program records, clinical study documentation, depositions and exhibits, trial exhibits, trial transcripts, privilege logs, and other court documents. Processed documents are being made public on a rolling basis with monthly releases expected from 2024-2026.


JUUL Labs Collection Update

346,902 new JUUL Labs documents were uploaded today!

This new batch of documents includes customer complaint files, weekly social media reports, international markets retail strategies, and more.

In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina.


Education and Research Updates


Opioid Crisis Timeline

Through OIDA documents, we can see the opioid crisis unfold. A new research resource, the timeline, introduces important pivot points in the epidemic by guiding readers to primary source documents, relevant scholarship, and contemporaneous journalistic accounts about the crisis.



New Papers and Publications

Thursday, June 27, 2024

IDL Surpasses 20 Million Documents!

JUUL Labs Collection

Today's addition of 289,868 new JUUL Labs documents has brought the Industry Documents Library's total number of documents to over 20 Million!

This new batch of documents includes customer complaint files, weekly social media reports, international markets retail strategies, and more. In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina.

Philip Morris International Collection

The University of Bath's Tobacco Control Research Group (TCRG) analyzed a small batch of newly added Philip Morris International (PMI) documents and found the tobacco company attempted to influence science and public health policy in Japan by covertly funding research and expert networks.

Read more about their key findings as well as the newly published article in Nicotine & Tobacco Research: “Keep it a secret”: leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profit

New Papers and Publications

Thursday, May 30, 2024

393,760 new JUUL Labs documents!

393,760 new JUUL Labs documents were uploaded today! This new batch includes customer complaint files, weekly social media reports, international retail strategies, and more. The image is from a JUUL Brand Review slide deck, one of over 500 new JUUL Labs presentation files added to IDL this month.

slides from a JUUL Brand Review presentation deck

In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina.

Our Archivists are working hard behind the scenes to ensure certain sensitive personal information is redacted and that any technical issues are resolved before the documents make their way onto the IDL. Stay tuned for continued monthly uploads through 2024!


OIDA Symposium

The Opioid Industry Documents Archive (OIDA) hosted a successful national symposium earlier this month. This unique virtual discussion offered a series of complementary panels demonstrating OIDA’s value in addressing fundamental questions of importance to health policy experts, archivists and historians.

OIDA symposium YouTube Playlist
Recordings are now available on YouTube and on the symposium webpage. Chapter markers on each video make it possible to navigate directly to specific presentations. These are linked within the agenda on the symposium website for ease of access.

Thank you to everyone who attended and especially to our amazing panel of speakers!


Fourth Workshop on Scientific Archives

This year's workshop will be held on June 5th and 6th in the UCSF Library! Specific themes discussed include:

  • Collaboration between scientists and archivists to best capture contemporary material
  • Appraisal of science and technology archives
  • Curating and making accessible science and technology archives to support both humanities research and scientific reuse
  • The description of specialist collections from a non-scientific perspective
  • Archives and scientific data management and usage
  • Public outreach and communication
Of particular note is the presentation on Day 2 by UCSF's Dan Kabella, Kelly Ray Knight, Dorie Apollonio, and Halle Young: Opioid Industry Documents Archive reveals the industry's role in AI-enabled prescription drug monitoring programs.


Call for Proposals: Advancing Digital Health Humanities Institute

UCSF Archives and Special Collections is seeking applicants for The Advancing Digital Health Humanities Institute (ADHHI), hosted by the University of California, San Francisco (UCSF) and funded through the National Endowment for the Humanities Institutes for Advanced Topics in the Digital Humanities.

In particular, the ADHHI is looking for digital health humanities projects that plan to work with data to answer humanistic research questions from a range of approaches and disciplines. Successful applicants should have a strong knowledge of their intended data set, and their research questions should be defined in relation to this material. Applicants do not need to be experts in a proposed analytical method or tool. ADHHI is most interested in projects that ask questions about human health, illness, ability, and the culture of care using historical materials and archival datasets.

More information and application

Thursday, April 25, 2024

New OIDA Collection and More JUUL Labs Documents

Collection Updates

New OIDA Collection - Poppell v. Cardinal Health
Poppell v. Cardinal Health Litigation Documents consists of transcripts, interrogatories, briefs and motions, complaint and answers, orders, and trial materials.

On March 1, 2023, a jury cleared wholesale drug distributors Cardinal Health Inc., McKesson Corporation, and J M Smith Corporation against claims that they violated Georgia’s Drug Dealer Liability Act and the state’s Racketeer Influenced and Corrupt Organizations (RICO) statute when supplying pharmacies with opioids. The 21 plaintiffs are family members of individuals who became addicted to opioids. It was the first lawsuit to come to trial brought by individual victims of the opioid crisis against pharmaceutical companies rather than by government entities.

The defendants, which also include pharmacies, pharmacy owners, and pharmacists, were charged for actions related to the illegal sales, marketing, and distribution of controlled substances. The allegations included ignoring warnings by the Drug Enforcement Agency (DEA), filling pharmacy orders without a legitimate medical need, failing to report excessive purchases and unusual and suspicious orders, and violating their obligations to prevent diversion.

The records in this collection were provided to OIDA by the law office of Bondurant Mixson & Elmore LLP. Documents in the collection include trial and hearing transcripts, trial exhibit lists, trial witness lists, statements of fact, expert disclosures, responses to requests for production of documents, briefs in support of motion to dismiss, and orders to seal records. The documents detail the roles and responsibilities of pharmacies, pharmacists, and distributors in dispensing opioid medication within the regulatory system, specifically related to efforts to prevent drug abuse and diversion.

JUUL Labs Documents
139K new JUUL Labs documents were uploaded. In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina. Our Archivists are working hard behind the scenes to ensure certain sensitive personal information is redacted and that any technical issues are resolved before the documents make their way onto the IDL. Stay tuned for continued monthly uploads through 2024!

Final uploads from the Minnesota Tobacco Documents Depository
We are pleased to report the upload of the final batch of documents from the Minnesota Tobacco Documents Depository reconciliation project.
The final set of 32 video files were part of a batch of trial exhibits and other materials used in litigation and stored in the depository. We have added these files to our DATTA collection, which holds trial transcripts and other resources.

On September 1, 2021, as a result of the expiration of the 2006 federal court order for document disclosure, the tobacco industry’s large warehouse of paper records in Minnesota closed its doors to the public. In advance of this permanent closure, the IDL team worked to complete a full reconciliation of our records, comparing them with the tobacco company indices to ensure we collected and preserved every document we could. A big thank you to the MN Historical Society archivists for their assistance with identifying and digitizing missing files. This included audiovisual materials, trial exhibits, and the content of computer disks that had not been previously available.


Education and Research Updates

The Opioid Industry Documents Archive (OIDA) is hosting a national symposium, Monday, May 13 through Thursday, May 16, from noon-2:30 PM (ET) / 9:00 AM-11:30 AM (PT). This unique symposium offers a series of complementary panels that will demonstrate OIDA’s value in addressing fundamental questions of importance to health policy experts, archivists, and historians.

For more details on speakers and how to register, please visit https://oida-resources.jhu.edu/oida-national-symposium-2024/.

Presentations
Chris Shaffer, Anne Seymour, and Kevin Hawkins will present "New Ways to Engage Users and Provide Access to Primary Source Documents Arising from the Opioid Industry" at the Medical Library Association's 2024 conference in Portland, Ore., May 18-21.

Rachel Taketa, Kate Tasker, and Melissa Ignacio presented "Redirect: Navigating a Major Website Redesign at the UCSF Industry Documents Library" for the Society of California Archivists at their virtual annual general meeting on April 15-19.

New Research Feature - Bulk Document Download
We've added a "Download Selected" option that will create a zipped folder of all selected documents (PDF, text and metadata) in your search results. By default the search shows 20 results at a time, but you can increase that to up to 200. You'll need to log in to your Industry Documents Library account to use this feature. (Click on My Library to create an account if you don't already have one!)

Thursday, April 18, 2024

UCSF-JHU Opioid Industry Documents Archive Announces National Symposium

The Opioid Industry Documents Archive (OIDA) is hosting a national symposium, Monday, May 13 through Thursday, May 16, noon-2:30 PM (ET) / 9:00 AM-11:30 AM (PT). This unique virtual symposium offers a series of complementary panels that will demonstrate OIDA’s value in addressing fundamental questions of importance to health policy experts, archivists and historians.

  

Dates: Monday, May 13 through Thursday, May 16 – each day noon to 2:30 PM ET

Day 1: Health Policy and Law (Monday, May 13)

  • Keith Ellison, Minnesota Attorney General’s Office
  • Aaron Kesselheim, Harvard University
  • Regina LaBelle, Georgetown University

This group of experts will explore how laws and policies are being developed to prevent further harms from the opioid crisis, and the critical role of document disclosure as a means to improve public health.


Day 2: Information Science (Tuesday, May 14)
  • Laurie Allen, Library of Congress
  • Rob Sanderson, Yale University
  • Ben Lee, University of Washington

In the digital age, organizational records are being produced on a scale that dwarfs physical archives and even digital archives based only on electronic documents. Speakers will talk about the challenges and opportunities of managing and providing access to massive digital collections like OIDA.


Day 3:History and Science of Medicine (Thursday, May 16)
  • David Courtwright, University of North Florida
  • Antoine Lentacker, University of California, Riverside
  • Liz Chiarello, Saint Louis University

This interdisciplinary panel will discuss the ways in which OIDA collections are an important gateway into telling new stories and developing new analyses about one of the most impactful drug epidemics in U.S. history.


For more details on speakers and how to register, please visit https://oida-resources.jhu.edu/oida-national-symposium-2024/.
Thursday, March 07, 2024

UCSF-JHU Opioid Industry Documents Archive Launches OIDA Curriculum Library

The Opioid Industry Documents Archive (OIDA), a collaborative undertaking between the University of California, San Francisco and Johns Hopkins University, announces the launch of the OIDA Curriculum Library, a resource created to facilitate use of OIDA documents in the classroom.

The OIDA Curriculum Library provides materials that introduce students at the undergraduate and graduate level to the role of corporate tactics in the opioid crisis as demonstrated by documents held in the Archive. The Library contains lectures and classroom activities of various lengths that provide an overview of the opioid crisis and specifically address the corporate marketing strategies used by pharmaceutical and consulting companies involved in the manufacturing, sales and distribution of opioids.

"Through the Library, we hope to make accessible to students these documents that corporations have kept secret until they were exposed through litigation," said Dr. Cecília Tomori, associate professor and director of Global Public Health and Community Health at the Johns Hopkins School of Nursing, with a joint appointment at the Johns Hopkins Bloomberg School of Public Health. "It's my hope that the Curriculum Library makes it easy for faculty to motivate their students to delve deeper into the documents and use them in the service of improving our current response to the opioid crisis and to prevent future ones."

The Curriculum Library also contains an annotated bibliography of relevant resources—scholarly articles, books, investigative journalism, documentaries, etc.—for use in the classroom. These materials have been pilot tested and refined by the OIDA team in a variety of courses ranging from undergraduate and graduate level public health courses to courses on substance use and health policy for health professionals such as medical and nursing students.

“The US opioid crisis is one of the worst public health disasters to date, claiming more lives since 1999 than in the worst of the HIV/AIDs epidemic,” said Dr. Kelly Ray Knight, professor at the UCSF School of Medicine. “It is critical that students understand the behaviors of industry and regulators that created the opioid crisis through these newly developed OIDA educational materials. These are the commercial determinants of health that set in motion the conditions under which hundreds of thousands of American lives are still lost every year.”

“The archive brings to life for students the complexity and challenges of policy making in a world of intrenched interests,” said John Colmers, Johns Hopkins Medicine vice president for health care transformation and strategic planning, former Secretary of the Maryland Department of Health and Mental Hygiene (DHMH), and senior associate in the Johns Hopkins Bloomberg School of Public Health. “The legacy of the discovery from the successful litigation will live long in the public domain, and it can be used to arm the next generation of public health leaders for the challenges ahead.”

OIDA was launched by UCSF and Johns Hopkins in March 2021 as a free public resource. The digital repository includes publicly disclosed documents arising from litigation brought against opioid manufacturers, distributors, pharmacies and consultants by local and state governments and tribal communities.

The Archive contains more than 12.6 million pages in 3 million documents and is expected to continue to grow for years to come. Documents are full-text searchable and include an array of relevant materials from many different companies, including emails, memos, presentations, sales reports, budgets, audit reports, Drug Enforcement Administration briefings, meeting agendas and minutes, expert witness reports and trial transcripts.

OIDA may be of use to many different parties, including individuals and communities harmed by the opioid crisis, as well as the media, health care practitioners, students, lawyers, and researchers. Major news outlets such as the New York Times and academic resources like Evidence & Policy and the American Journal of Public Health have published investigative reports and analysis using OIDA documents.

To learn more and access the OIDA Curriculum Library, visit https://oida-resources.jhu.edu/oida-curriculum-library/.

Friday, March 01, 2024

New JUUL Labs Documents and Opioid Industry Documents Posted

Tobacco Industry Documents

253,000 new documents were added to the JUUL Labs Collection today! These documents come to us from JUUL Lab's 2021 settlement with North Carolina.
UNC-Chapel Hill and UCSF will continue to publish the remaining documents monthly, concluding the project in 2025.
Screenshot from JUUL Labs presentation on influencer events - document lpyv0284

Opioid Industry Documents

We have added a new collection, the US v. Doud Litigation Documents.
On February 2, 2022, a jury convicted Laurence F. Doud III of conspiring to unlawfully distribute oxycodone and fentanyl and of conspiring to defraud the Drug Enforcement Administration (DEA). He was sentenced to 27 months in prison.
Doud was charged for actions related to his role as CEO of pharmaceutical distributor Rochester Drug Cooperative (“RDC”) between 2012 and 2017. Doud and other defendants with RDC failed to report suspicious pharmacy orders (such as unusual sales volumes, cash purchases, and out-of-state purchasers) to the DEA, misrepresented RDC’s adherence to written compliance policies and procedures, and failed to conduct due diligence on new customers who purchased opioids and other narcotics.
The records in this collection were provided to OIDA by the U.S. Attorney’s Office for the Southern District of New York. Documents in the collection include email correspondence, DEA reports and reporting logs, pharmacy order records, Automation of Reports and Consolidated Orders System (ARCOS) reports, as well as call logs and transcripts. The documents detail the wholesale distribution process, sales and market share information of wholesalers, as well as compliance and audit reports submitted to the DEA.

Education and Research Updates

2023 Carol Weiss Prize -
Congratulations to Brian W. Gac, Hanna Yakubi & UCSF Professor Dorie Apollonio! Their paper in Evidence & Policy, based upon files in the Opioid Industry Documents Archive, was selected as recipient of the journal's 2023 Carol Weiss Prize recognizing outstanding contributions from early career scholars. The editorial board "appreciated the authors' innovative use of an enormous corpus of documents to explore the (in this case, problematic) intersection of evidence and policy in ways that would not be possible through direct surveys or interviews."

PREV
NEXT